Your session is about to expire
← Back to Search
Demand-driven delivery followed by free-flow delivery for Laughing Gas
N/A
Waitlist Available
Led By Carilynne Yarascavitch, BSc DDS MSc
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed immediately after breathing through each mechanism for 2 minutes
Awards & highlights
Study Summary
This trial will compare two methods of gas delivery in a dental setting: 1) demand-driven (DD) and 2) free-flow (FF).
Eligible Conditions
- Laughing Gas
- Dentistry
- Drug Delivery System
- Self-Care
- Feasibility
- Inhalation Drug Administration
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ procedure (assessed for the duration of time when the patient is breathing from either delivery system)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~procedure (assessed for the duration of time when the patient is breathing from either delivery system)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Comfort of the demand-driven gas delivery mechanism
Feasibility of the demand-driven gas delivery mechanism
Trial Design
2Treatment groups
Experimental Treatment
Group I: Free-flow delivery followed by demand-driven deliveryExperimental Treatment2 Interventions
Participants will inspire 100% oxygen through their nose with the gas delivery device set to a free-flow delivery setting through a nasal hood for 2 minutes followed by inspiration of 100% oxygen through their nose with the gas delivery device set to a free-flow delivery setting through a nasal hood for 2 minutes.
Group II: Demand-driven delivery followed by free-flow deliveryExperimental Treatment2 Interventions
Participants will inspire 100% oxygen through their nose with the gas delivery device set to a demand-driven delivery setting through a nasal hood for 2 minutes followed by inspiration of 100% oxygen through their nose with the gas delivery device set to a free-flow delivery setting through a nasal hood for 2 minutes.
Find a Location
Who is running the clinical trial?
University of TorontoLead Sponsor
689 Previous Clinical Trials
1,018,543 Total Patients Enrolled
O-Two Medical TechnologiesUNKNOWN
Carilynne Yarascavitch, BSc DDS MScPrincipal InvestigatorUniversity of Toronto
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger